Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125700713 | 12570071 | 3 | F | 20160831 | 20160719 | 20160912 | EXP | GB-TEVA-676511ACC | TEVA | 69.00 | YR | M | Y | 75.00000 | KG | 20160912 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125700713 | 12570071 | 1 | PS | SERTRALINE | SERTRALINE HYDROCHLORIDE | 1 | Oral | WITHDRAWN BEFORE 13-JUN-2016? | Y | U | 76465 | 50 | MG | ||||||
| 125700713 | 12570071 | 2 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 0 | 75 | MG | |||||||||
| 125700713 | 12570071 | 3 | C | ATORVASTATIN | ATORVASTATIN | 1 | Oral | 0 | 40 | MG | |||||||||
| 125700713 | 12570071 | 4 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | PNR BASIS | 0 | 15 | MG | |||||||||
| 125700713 | 12570071 | 5 | C | LISINOPRIL. | LISINOPRIL | 1 | Oral | 0 | 20 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125700713 | 12570071 | 1 | Stress |
| 125700713 | 12570071 | 2 | Prophylaxis |
| 125700713 | 12570071 | 3 | Prophylaxis |
| 125700713 | 12570071 | 5 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125700713 | 12570071 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125700713 | 12570071 | Amnesia | |
| 125700713 | 12570071 | Anger | |
| 125700713 | 12570071 | Asthenia | |
| 125700713 | 12570071 | Decreased appetite | |
| 125700713 | 12570071 | Diarrhoea | |
| 125700713 | 12570071 | Disturbance in attention | |
| 125700713 | 12570071 | Dizziness postural | |
| 125700713 | 12570071 | Dyskinesia | |
| 125700713 | 12570071 | Eye pain | |
| 125700713 | 12570071 | Haemorrhage subcutaneous | |
| 125700713 | 12570071 | Headache | |
| 125700713 | 12570071 | Heart rate increased | |
| 125700713 | 12570071 | Mental disorder | |
| 125700713 | 12570071 | Nausea | |
| 125700713 | 12570071 | Palpitations | |
| 125700713 | 12570071 | Psychiatric symptom | |
| 125700713 | 12570071 | Somnolence | |
| 125700713 | 12570071 | Thinking abnormal | |
| 125700713 | 12570071 | Tinnitus | |
| 125700713 | 12570071 | Vertigo |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125700713 | 12570071 | 1 | 20160602 | 0 | ||
| 125700713 | 12570071 | 2 | 20141113 | 0 | ||
| 125700713 | 12570071 | 3 | 20141223 | 0 | ||
| 125700713 | 12570071 | 4 | 20160125 | 0 | ||
| 125700713 | 12570071 | 5 | 20150402 | 0 |